Scott Leftwich - Director at Calidi Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CLDI on NYSE, CLDWW on OTC
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Scott Leftwich - trading volume in the past year for Calidi Biotherapeutics, Inc.

Holdings reported by Scott Leftwich for Calidi Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 131K $261K $2.00 Aug 21, 2025 Direct
Common Stock 14.7K $8.66K $0.59 Aug 21, 2025 By SECBL, LLC
Common Stock 1.31K $772 $0.59 Aug 21, 2025 By WEBCL, LLC
Non-Qualified Stock Options (right to buy) 137K Jul 9, 2025 Direct Common Stock
Warrant (right to buy) 125K Aug 21, 2025 Direct Common stock

Transactions reported by Scott Leftwich for Calidi Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.